Methods and compositions for the evaluation of renal injury using hyaluronic acid
AssigneeAstute Medical, Inc.
InventorsJoseph Anderberg, Jeff Gray, Paul McPherson, Kevin Nakamura, James Patrick Kampf, Kai Singbartl, John A. Kellum
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more of hyaluronic acid (HA) as diagnostic and prognostic biomarker assays in renal injuries.
Claims40
A method for evaluating renal status in a subject not receiving renal replacement therapy, comprising:
- performing one or more assays configured to detect one or more of HA on a body fluid sample obtained from the subject to provide one or more assay results;
- and
- correlating the assay result(s) to one or more of risk stratification, prognosis, classifying and monitoring of the renal status of the subject.
Urine measurement of HA for the risk stratification, prognosis, classifying and monitoring of renal status of a subject not receiving renal replacement therapy.
Urine measurement of HA for the risk stratification, prognosis, classifying and monitoring of renal status of a subject not in acute renal failure.
Urine measurement of HA for assigning an increased likelihood of progressing to a worsening RIFLE stage to a subject, relative to the subject's current RIFLE stage.
Dependencies are inferred from the claim text.